Form D Explorer
AirNexis Therapeutics, Inc. · CIK 2116194

Report a data issueCitable research briefCompare issuerPrivate research collection

AirNexis Therapeutics, Inc.

CIK 2116194 · Corporation · Inc. DELAWARE · PALO ALTO, California · Biotechnology
Filings
1
Original notices
1
Amendments
0
Activity
Mar 9, 2026
through Mar 9, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot

Form D · Mar 9, 2026

Reported offering amount
$200,000,000
Reported exemptions
Rule 506(b)
Reported amount sold
$62,000,000

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Form D filings (1)